terraplasma medical successfully completes financing
Bacteria – especially multi-resistant germs – are one of the greatest problems in difficult-to-heal chronic and acute wounds. The terraplasma medical device aims to optimize the wound treatment process carried out by medical professionals and to reduce the pain suffered by the patients and increase their quality of life.
In order to achieve this vision, terraplasma medical is developing a mobile, battery-powered medical device for inpatient and outpatient treatment of chronic and acute wounds, which kills even multi-resistant bacteria by applying cold plasma. Plasma is often referred to as a fourth aggregate state (in addition to solid, liquid and gaseous) and describes a particle mixture whose actual components are partially charged components.
In a clinical study led by the City Clinic Schwabing (Munich Municipal Hospital Group), Germany, and the University Hospital Regensburg, Germany, in cooperation with Prof Dr Gregor Morfill, former director of the Max Planck Institute in Garching, and PD Dr Julia Zimmermann, CEO of terraplasma medical, over 300 patients were treated with cold plasma. The clinical study showed a significant reduction of the bacterial load in chronic wounds (irrespective of the species and the level of resistance of the bacteria to antibiotics) and enhanced and faster wound healing. Moreover, a faster and improved healing of skin graft wounds as well as faster healing of lesions and reduction of acute pain from Herpes Zoster could be observed.
terraplasma medical GmbH was founded by terraplasma GmbH, a spin-off from the Max Planck Institute of extraterrestrial Physics, and Dynamify GmbH.
For further information, please visit www.terraplasma-medical.com
About Max Planck Innovation
Max Planck Innovation is responsible for the technology transfer of the Max Planck Society and, as such, the link between industry and basic research. With our interdisciplinary team we advise and support scientists of the Max Planck Institutes in evaluating their inventions, filing patents and founding companies. We offer industry a unique access to the innovations of the Max Planck Institutes. Thus, we perform an important task: the transfer of basic research results into products, which contribute to the economic and social progress.